tag:www.gov.uk,2005:/government/organisations/medicines-and-healthcare-products-regulatory-agency Medicines and Healthcare products Regulatory Agency - Activity on 51²è¹Ý HM Government 2025-05-15T10:30:20Z /drug-safety-update/thiopurines-and-intrahepatic-cholestasis-of-pregnancy#2025-05-15T10:30:20Z 2025-05-15T10:30:20Z Thiopurines and intrahepatic cholestasis of pregnancy Intrahepatic cholestasis of pregnancy (ICP) has been rarely reported in patients treated with azathioprine products and is believed to be a risk applicable to all drugs in the thiopurine class (azathioprine, mercaptopurine and tioguanine). Cholestasis of pregnancy associated with thiopurines tends to occur earlier in pregnancy than non drug-induced cholestasis of pregnancy, and elevated bile acid levels may not reduce with ursodeoxycholic acid. /guidance/register-a-homeopathic-medicine-or-remedy#2025-05-14T16:09:31Z 2025-05-14T16:09:31Z Register a homeopathic medicine Information about how to register your homeopathic medicinal product through the Simplified Homeopathic Registration Scheme or the UK Homeopathic National Rules Scheme /government/publications/advertising-investigations-april-2025#2025-05-14T13:53:59Z 2025-05-14T13:53:59Z Decision: Advertising Investigations: April 2025 Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines. /government/publications/medical-devices-given-exceptional-use-authorisations-during-the-covid-19-pandemic#2025-05-14T07:55:23Z 2025-05-14T07:55:23Z Decision: Medical devices given exceptional use authorisations during the COVID-19 pandemic List of manufacturers and their medical devices granted an exemption by MHRA. The list also includes manufacturers whose exemption expired or was cancelled. /drug-device-alerts/field-safety-notices-5-to-8-may-2025#2025-05-14T07:47:13Z 2025-05-14T07:47:13Z Field Safety Notices: 5 to 8 May 2025 List of Field Safety Notices from 5 to 8 May 2025. /government/publications/orphan-registered-medicinal-products#2025-05-13T11:26:11Z 2025-05-13T11:26:11Z Decision: Orphan registered medicinal products A list of authorised orphan medicinal products registered by the UK licensing authority. /drug-device-alerts/class-4-medicines-notification-chemidex-pharma-ltd-various-products-el-25-a-slash-21#2025-05-13T10:00:04Z 2025-05-13T10:00:04Z Class 4 Medicines Notification, Chemidex Pharma Ltd, Various Products, EL(25)A/21 Chemidex Pharma Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in their topical steroid products does not contain all the required safety information. Cartons for the products/batches listed are missing side effect information related to Visual Disturbances. /government/publications/parallel-import-licences-granted-in-2025#2025-05-13T08:50:33Z 2025-05-13T08:50:33Z Decision: Parallel import licences granted in 2025 Parallel import licences granted in 2025. /government/publications/international-recognition-procedure#2025-05-13T08:37:02Z 2025-05-13T08:37:02Z Guidance: International Recognition Procedure How to use the procedure for medicines licensing applications. /government/publications/marketing-authorisations-granted-in-2025#2025-05-13T08:36:22Z 2025-05-13T08:36:22Z Decision: Marketing authorisations granted in 2025 Marketing authorisations granted in 2025. /government/news/meet-the-women-helping-ensure-that-digital-mental-health-technologies-are-safe-effective-and-developed-considering-the-needs-of-the-people-who-use-th#2025-05-12T23:00:00Z 2025-05-12T23:00:00Z Meet the women helping ensure that digital mental health technologies are safe, effective and developed considering the needs of the people who use them Mental health apps are everywhere, offering everything from mood tracking to therapy. But with so many options, how can people tell what these tools actually do? /government/news/mhra-approves-first-uk-treatment-for-congenital-thrombotic-thrombocytopenic-purpura-cttp#2025-05-12T16:41:15Z 2025-05-12T16:41:15Z MHRA approves first UK treatment for congenital thrombotic thrombocytopenic purpura (cTTP)  As with all products, the MHRA will keep its safety under close review. /guidance/medicines-apply-for-a-parallel-import-licence#2025-05-12T15:22:24Z 2025-05-12T15:22:24Z Medicines: apply for a parallel import licence How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application. /government/consultations/consultation-on-the-international-council-for-harmonisation-ich-e6-r3-guideline-for-good-clinical-practice-annex-2#2025-05-12T13:25:48Z 2025-05-12T13:25:48Z Consultation on the International Council for Harmonisation ICH E6 (R3) Guideline for Good Clinical Practice Annex-2 The ICH Expert Working Group for ICH E6(R3) (EWG) has been updating the ICH E6(R2) GCP guideline. The MHRA represents the Pharmaceutical Inspection Co-operation Scheme (PIC/s) in the EWG. /government/news/mhra-approves-worlds-first-low-carbon-version-of-copd-inhaler-trixeo-aerosphere#2025-05-12T04:17:30Z 2025-05-12T04:17:30Z MHRA approves world’s first low-carbon version of COPD inhaler Trixeo Aerosphere As with all medicines, the MHRA will continue to monitor the safety and effectiveness of Trixeo Aerosphere /government/publications/the-northern-ireland-mhra-authorised-route-nimar#2025-05-09T10:14:01Z 2025-05-09T10:14:01Z Guidance: The Northern Ireland MHRA Authorised Route (NIMAR) The UK government has introduced the Northern Ireland MHRA Authorised Route (NIMAR). This new route for supply became operational 1 January 2022. /government/consultations/consultation-on-the-international-council-for-harmonisation-ich-m13b-guideline-on-bioequivalence-for-immediate-release-solid-oral-dosage-forms#2025-05-08T23:01:00Z 2025-05-08T23:01:00Z Consultation on the International Council for Harmonisation (ICH) M13B Guideline on Bioequivalence for Immediate-Release Solid Oral Dosage Forms The ICH Expert Working Group (EWG) for ICH M13B has been drafting the second guideline in the series which describes the scientific and technical aspects of study design and data analysis to support bioequivalence (BE) assessment for orally administered immediate-release solid oral dosage forms. /government/publications/medicines-and-healthcare-products-regulatory-agency-gpc-spending-over-500-2024-25#2025-05-08T16:23:57Z 2025-05-08T16:23:57Z Transparency data: Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2024-25 MHRA transactions over £500 made using the government procurement card (GPC). /government/publications/medicines-and-healthcare-products-regulatory-agency-gpc-spending-over-500-2023-24#2025-05-08T16:23:56Z 2025-05-08T16:23:56Z Transparency data: Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2023-24 MHRA transactions over £500 made using the government procurement card (GPC). /government/publications/medicines-and-healthcare-products-regulatory-agency-gpc-spending-over-500-2022-23#2025-05-08T16:23:55Z 2025-05-08T16:23:55Z Transparency data: Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2022-23 MHRA transactions over £500 made using the government procurement card (GPC).